Discontinuation rate and reason for discontinuation after sodium-glucose cotransporter 2 inhibitor prescription in real clinical practice.

Hyunah KimSeung-Hwan LeeJae-Hyoung ChoHyunyong LeeHyeon Woo YimKun-Ho YoonHun Sung Kim

Published in: Journal of clinical pharmacy and therapeutics (2020)

The incidence of side effects with dapagliflozin was not as high as expected. Physicians should consider instructions prior to prescribing dapagliflozin so that its discontinuation would decrease considerably.

Keyphrases

primary care
clinical practice
risk factors
emergency department
drug induced